stage IV mantle cell lymphoma
Showing 9976 - 10000 of >10,000
Osteoarthritis, Knee Trial in Jakarta Pusat (Mesenchymal Stem Cells with Arthoscopy, Mesenchymal Stem Cells without Arthoscopy,
Recruiting
- Osteoarthritis, Knee
- Arthroscopy with Mesenchymal Stem Cells + Secretome + Secretome
- +3 more
-
Jakarta Pusat, DKI Jakarta, IndonesiaGatot Soebroto Hospital
Sep 25, 2022
Non Small Cell Lung Cancer Trial in Buffalo (SBRT)
Recruiting
- Non Small Cell Lung Cancer
- SBRT
-
Buffalo, New YorkRoswell Park Cancer Institute
Sep 27, 2022
Non-alcoholic Fatty Liver Disease, Liver Cirrhosis Trial in Worldwide (CC-90001, Placebo)
Terminated
- Non-alcoholic Fatty Liver Disease
- Liver Cirrhosis
- CC-90001
- Placebo
-
Phoenix, Arizona
- +121 more
Oct 19, 2021
Vasovagal Syncope Trial in Canada, Poland, United States (midodrine HCl, matching )
Active, not recruiting
- Vasovagal Syncope
- midodrine hydrochloride
- matching placebo
-
Minneapolis, Minnesota
- +16 more
Nov 1, 2022
Neuromyelitis Optica Spectrum Disorder Trial in Barcelona (Ravulizumab)
Recruiting
- Neuromyelitis Optica Spectrum Disorder
-
Barcelona, SpainClinical Trial Site
Jul 6, 2022
Indocyanine Green-guided Systematic Pelvic Lymphadenectomy in
Completed
- Endometrial Cancer
- Cervical Cancer
- Indocyanine green-guided systematic pelvic lymphadenectomy
- (no location specified)
Jan 29, 2023
Solid Tumor, Microsatellite Instability-High (MSI-H) Solid Tumors, Cutaneous Melanoma Trial in Worldwide (LY3300054,
Active, not recruiting
- Solid Tumor
- +4 more
- LY3300054
- +4 more
-
Nashville, Tennessee
- +14 more
Jul 21, 2022
Hematopoietic Organs; Disorder Trial in Hong Kong (Total lymphoid irradiation)
Recruiting
- Hematopoietic Organs; Disorder
- Total lymphoid irradiation
-
Hong Kong, Hong KongHong Kong Children's Hospital
Oct 4, 2023
Intraperitoneal Chemotherapy Versus Triweekly Chemotherapy
Recruiting
- Intraperitoneal Chemotherapy, Bevacizumab, Ovarian Cancer
-
Banqiao, New Taipei, TaiwanDepartment of Obstetrics and Gynecology, Far Eastern Memorial Ho
Jan 1, 2023
Vitiligo Trial in Worcester (Metformin Hydrochloride)
Not yet recruiting
- Vitiligo
- Metformin Hydrochloride
-
Worcester, MassachusettsUMass Chan Medical School
Nov 6, 2022
Immunodeficiencies, Immune Dysregulation Syndromes Trial in Philadelphia (Apha/beta T and CD19+ cell depletion using CliniMACS
Recruiting
- Immunodeficiencies
- Immune Dysregulation Syndromes
- Apha/beta T and CD19+ cell depletion using CliniMACS device
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Nov 8, 2022
Predictive Factor of Pathologic Complete Response After
Completed
- Rectum Cancer
-
Bangkok, Bankok, ThailandChairat Supsamutchai
May 15, 2022
Stem Cell Transplant Trial in Boston, Durham, Seattle (Palliative Care Intervention, Standard Transplant Care)
Active, not recruiting
- Stem Cell Transplant
- Palliative Care Intervention
- Standard Transplant Care
-
Boston, Massachusetts
- +2 more
Aug 23, 2022
Hypertension, Vascular Diseases, Cardiovascular Diseases Trial in Worldwide (Paradise Renal Denervation System, Renal Angiogram)
Active, not recruiting
- Hypertension
- +2 more
- Paradise Renal Denervation System
- Renal Angiogram
-
Birmingham, Alabama
- +58 more
Mar 28, 2022
Molecules Associated With Progression of Prediabetes to Overt
Recruiting
- Type2 Diabetes Mellitus
- Pre Diabetes
-
London, United KingdomUniversity of Roehampton
May 17, 2022
Parkinson Disease, Freezing of Gait Trial in Beijing (Vibrotactile foot device (Smart shoe))
Recruiting
- Parkinson Disease
- Freezing of Gait
- Vibrotactile foot device (Smart shoe)
-
Beijing, ChinaXuanwu Hospital
Nov 21, 2023
Classical Hodgkin Lymphoma Trial in Cologne (Brentuximab Vedotin)
Recruiting
- Classical Hodgkin Lymphoma
- Brentuximab Vedotin
-
Cologne, Germany1st Department of Medicine, Cologne University Hospital
Nov 26, 2020
Melanoma Trial in Worldwide (Talimogene Laherparepvec, Pembrolizumab, Placebo)
Terminated
- Melanoma
- Talimogene Laherparepvec
- +2 more
-
Birmingham, Alabama
- +160 more
Nov 10, 2022
Sickle Cell Disease, Sickle Cell Anemia Trial run by the NHLBI (Biotin label)
Recruiting
- Sickle Cell Disease
- Sickle Cell Anemia
- Biotin label
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 11, 2022
Esophageal Achalasia, Transcranial Magnetic Stimulation, Repetitive, Vagus Nerve Motor Disorder Trial in Nanjing (Repetitive
Not yet recruiting
- Esophageal Achalasia
- +3 more
- Repetitive transcranial magnetic stimulation
- Sham
-
Nanjing, ChinaNanjing Drum Tower Hospital
Sep 6, 2023
Clinical and Laboratory Analysis of Familial Cancer
Completed
- Cancer
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
May 12, 2022
HIV-1-infection Trial in New York, Philadelphia, Nashville (INO-6160, 2 mg, Trimer-4571 / 100 mcg 3M-052-AF (5 mcg) + Alum (500
Recruiting
- HIV-1-infection
- INO-6160, 2 mg
- Trimer-4571 / 100 mcg 3M-052-AF (5 mcg) + Alum (500 mcg)
-
New York, New York
- +2 more
Apr 13, 2023
Head and Neck Squamous Cell Carcinoma Trial in United States (TAK-676, Carboplatin, 5-FU)
Completed
- Head and Neck Squamous Cell Carcinoma
- TAK-676
- +8 more
-
Shreveport, Louisiana
- +3 more
Oct 3, 2023